This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in Revolutionary FAR Overhaul, FAR Subpart 12, as supplemented with addit... This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in Revolutionary FAR Overhaul, FAR Subpart 12, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a separate solicitation will not be issued. This solicitation is issued as a Request for Quotation (RFQ). This solicitation is Unrestricted. This notice follow notices 36C26326Q0861 and 36C26326Q0753 The Omaha VA Medical Center (VAMC) has a requirement for a reliable FDA registered source of blood products and services for the treatment of patients. All products will be used for human administration, blood and blood products are considered domestic end times as they are drawn and processed in the United States of America. All referred patient testing results will be included in treatment of the patient based on clinical presentation. Apheresis services will be provided in accordance with written orders issued by the patient’s ordering physician. Contractor shall furnish all personnel, supplies, and facilities necessary to collect, process, store, and deliver human blood components and derivatives. The contractor shall supply the blood products and services which are listed on the Price/Cost Schedule. See attached RFQ 1449 document and other attachments. All questions shall be received no later than 12:00 PM CT Thursday, September 17, 2026. All offers shall be received by the CO no later than 05:00 PM CT Sunday, September 20, 2026. All offers shall be emailed to Joseph.Bennett@va.gov Emails shall include this RFQ number in the Subject Line: 36C26326Q1098.